MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

ABIOMED Company Profile (NASDAQ:ABMD)

Consensus Ratings for ABIOMED (NASDAQ:ABMD) (?)
Ratings Breakdown: 2 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $77.00 (17.24% upside)

Analysts' Ratings History for ABIOMED (NASDAQ:ABMD)
Show:
DateFirmActionRatingPrice TargetActions
5/9/2015Jefferies GroupReiterated RatingBuy$72.00 -> $83.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2015BTIG ResearchReiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2015Leerink SwannBoost Price TargetOutperform$72.00 -> $88.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2015Northland SecuritiesBoost Price TargetMarket Perform$40.00 -> $60.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/24/2015BTIG ResearchReiterated RatingPositiveView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/17/2015Leerink SwannBoost Price TargetOutperform$60.00 -> $72.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/29/2015BTIG ResearchReiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/29/2015Leerink SwannBoost Price TargetOutperform$43.00 -> $60.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/28/2015Northland SecuritiesUpgradeUnder Perform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/28/2015Jefferies GroupReiterated RatingBuy$45.00 -> $56.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/5/2015Jefferies GroupReiterated RatingBuy$37.00 -> $45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/3/2014BTIG ResearchDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/24/2014Leerink SwannInitiated CoverageOutperform$34.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/21/2014BTIG ResearchUpgradeNeutral -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/20/2014BTIG ResearchInitiated CoverageNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/10/2014WunderlichBoost Price TargetBuy$29.00 -> $35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/10/2013Benchmark Co.Reiterated RatingBuy$25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/7/2013Northland SecuritiesBoost Price TargetUnderperform$9.00 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/7/2013Jefferies GroupBoost Price TargetBuy$25.00 -> $30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/1/2013Benchmark Co.Initiated CoverageSpeculative Buy -> Buy$25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/7/2013 forward)